Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02296112
Title Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Vanderbilt-Ingram Cancer Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST